Sustained virological response to interferon plus ribavirin reduces liver-related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus

Cited in:

CrossRef

This article has been cited by:

1. 1
   José A. Mira, Juan Macías, ¿Podemos adelantar el diagnóstico de la respuesta virológica sostenida a las 12 semanas tras finalizar el tratamiento frente al VHC?, Enfermedades Infecciosas y Microbiología Clínica, 2012, 30, 1, 1

   CrossRef

2. 2
   Masao Omata, Tatsuo Kanda, Ming-Lung Yu, Osamu Yokosuka, Seng-Gee Lim, Wasim Jafri, Ryosuke Tateishi, Saeed S. Hamid, Wan-Long Chuang, Anuchit Chutaputti, Lai Wei, Jose Sollano, Shiv Kumar Sarin, Jia-Horng Kao, Geoffrey W. McCaughan, APASL consensus statements and management algorithms for hepatitis C virus infection, Hepatology International, 2012, 6, 2, 409

   CrossRef

3. 3
   D. E. FRANSEN van de PUTTE, K. FISCHER, R. J. De KNEGT, D. POSTHOUWER, K. J. Van ERPECUM, D. H. BIESMA, E. P. MAUSER-BUNSCHOTEN, Beneficial effect of successful HCV treatment in patients with inherited bleeding disorders, assessed by liver stiffness measurements, Haemophilia, 2012, 18, 3

   Direct Link:

   • Abstract
   • Full Article (HTML)
   • PDF(166K)
   • References
4. 4
   Mamta K. Jain, Emmanuel Seremba, Rafia Bhore, Doan Dao, Reeti Joshi, Nahid Attar, He-Jun Yuan, William M. Lee, Change in Fibrosis Score as a Predictor of Mortality Among HIV-Infected Patients with Viral Hepatitis, AIDS Patient Care and STDs, 2012, 26, 2, 73

   CrossRef

5. 5
   B. P. Linas, A. Y. Wong, B. R. Schackman, A. Y. Kim, K. A. Freedberg, Cost-effective Screening for Acute Hepatitis C Virus Infection in HIV-Infected Men Who Have Sex With Men, Clinical Infectious Diseases, 2012,

   CrossRef

6. 6
   Ramon Sanmartin, Elena de Felipe, Jordi Tor, Arantza Sanvicens, Eva Barluenga, Elisenda Martinez, Robert Muga, Antoni Jou, Isabel Ojanguren, Juan José López, Bonaventura Clotet, Cristina Tural, Effect of Liver Fibrosis on Long-Term Mortality in HIV/Hepatitis C Virus-Coinfected Individuals Who Are Evaluated to Receive Interferon Therapies in the Highly Active Antiretroviral Therapy Era, AIDS Research and Human Retroviruses, 2012, 120420065605003

   CrossRef

7. 7
   M. W. Hull, K. Rollet, A. Odueyungbo, S. Saeed, M. Potter, J. Cox, C. Cooper, J. Gill, M. B. Klein, Factors Associated With Discordance Between Absolute CD4 Cell Count and CD4 Cell Percentage in Patients Coinfected With HIV and Hepatitis C Virus, Clinical Infectious Diseases, 2012, 54, 12, 1798

   CrossRef

8. 8
   Anthony D. Martinez, Robert G. Gish, HCV In At Risk Populations: Who Can be Treated and How?, Current Hepatitis Reports, 2012, 11, 1, 1

   CrossRef

9. 9
   S.-M. Alavian, S. V. Tabatabaei, B. Behnava, Impact of erythropoietin on sustained virological response to peginterferon and ribavirin therapy for HCV infection: a systematic review and meta-analysis, Journal of Viral Hepatitis, 2012, 19, 2

   Direct Link:

   • Abstract
   • Full Article (HTML)
   • PDF(198K)
   • References
10. 10
    J. Macías, M. M. Viloria, A. Rivero, I. Santos, M. Márquez, J. Portilla, F. Di Lello, A. Camacho, J. Sanz-Sanz, G. Ojeda, R. Mata, J. Gómez-Mateos, J. A. Pineda, Lack of short-term increase in serum mediators of fibrogenesis and in non-invasive markers of liver fibrosis in HIV/hepatitis C virus-coinfected patients starting maraviroc-based antiretroviral therapy, European Journal of Clinical Microbiology & Infectious Diseases, 2012,

    CrossRef

11. 11
    Susanna Naggie, Mark S. Sulkowski, Management of Patients Coinfected With HCV and HIV: A Close Look at the Role for Direct-Acting Antivirals, Gastroenterology, 2012, 142, 6, 1324

    CrossRef

12. 12
    Karin Neukam, Angela Camacho, Antonio Caruz, Norma Rallón, Almudena Torres-Cornejo, Jürgen K. Rockstroh, Juan Macías, Antonio Rivero, José M. Benito, Luis F. López-Cortés, Jacob Nattermann, Jesús Gómez-Mateos, Vicente Soriano, Juan A. Pineda, Prediction of response to pegylated interferon plus ribavirin in HIV/hepatitis C virus (HCV)-coinfected patients using HCV genotype, IL28B variations, and HCV-RNA load, Journal of Hepatology, 2012, 56, 4, 788

    CrossRef

13. 13
    Hans L. Tillmann, John G. McHutchison, Zakim and Boyer's Hepatology, 2012,

    CrossRef

14. 14
    L.E. Taylor, A.K. DeLong, M.A. Maynard, S. Chapman, P. Gholam, J.T. Blackard, J. Rich, K.H. Mayer, Acute Hepatitis C Virus in an HIV Clinic: A Screening Strategy, Risk Factors, and Perception of Risk, AIDS Patient Care and STDs, 2011, 25, 10, 571

    CrossRef

15. 15
    Jennifer Y. Chen, Raymond T. Chung, Can We Use the “C” Word With Confidence? Cure for Chronic Hepatitis C, Gastroenterology, 2011, 140, 3, 766

    CrossRef

16. 16
    Javier Ena, Rosa F. Ruiz-de-Apodaca, Francisco Pasquau, Concepción Amador, Concepción Benito, Cross-sectional epidemiology of hepatitis C virus detection and treatment in HIV-infected patients, European Journal of Internal Medicine, 2011, 22, 1, 66

    CrossRef

17. 17
    McKenzie C. Ferguson, Current Therapies for Chronic Hepatitis C, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2011, 31, 1

    Direct Link:

    • Abstract
    • PDF(331K)
    • References
18. 18
    Sanjay Bhagani, Current treatment for chronic hepatitis C virus/HIV-infected individuals, Current Opinion in HIV and AIDS, 2011, 6, 6, 483

    CrossRef

19. 19
    Lionel Piroth, Direct-acting antivirals for hepatitis C virus infections in patients co-infected with human immunodeficiency virus, Clinics and Research in Hepatology and Gastroenterology, 2011, 35, S75

    CrossRef

20. 20
    Kyung-Ah Kim, Durability of a sustained virologic response in patients with chronic hepatitis C treated with peginterferon and ribavirin, The Korean Journal of Hepatology, 2011, 17, 1, 84

    CrossRef

21. 21
    Sang Bun Choi, Youn Jae Lee, Jae Ik Lee, Young Jin Song, Byoung Jin Choi, Jong Han Kim, Eun Uk Jung, Sung Jae Park, Sang Heon Lee, Ji Hyun Kim, Jung Sik Choi, Sam Ryong Jee, Sang Yong Seol, Durability of a sustained virological response in chronic hepatitis C patients treated with pegylated interferon alfa and ribavirin, The Korean Journal of Hepatology, 2011, 17, 3, 183

    CrossRef

22. 22
    J. Berenguer, M. A. von Wichmann, C. Quereda, P. Miralles, J. Mallolas, J. Lopez-Aldeguer, J. Alvarez-Pellicer, J. De Miguel, M. Crespo, J. M. Guardiola, M. J. Tellez, M. J. Galindo, S. Arponen, E. Barquilla, J. M. Bellon, J. Gonzalez-Garcia, P. Miralles, J. Cosin, J. C. Lopez, B. Padilla, M. Sanchez Conde, J. M. Bellon, I. Gutierrez, M. Ramirez, S. Carretero, T. Aldamiz-Echevarria, F. Tejerina, J. Berenguer, J. Alvarez-Pellicer, E. Rodriguez, J. R. Arribas, M. L. Montes, I. Bernardino, J. F. Pascual, F. Zamora, J. M. Pena, F. Arnalich, J. Gonzalez-Garcia, M. J. Bustinduy, J. A. Iribarren, F. Rodriguez-Arrondo, M. A. Von-Wichmann, M. Blanes, S. Cuellar, J. Lacruz, M. Montero, M. Salavert, J. Lopez-Aldeguer, P. Callau, J. M. Miro, J. M. Gatell, J. Mallolas, A. Ferrer, M. J. Galindo, E. Van den Eynde, M. Perez, E. Ribera, M. Crespo, J. Vergas, M. J. Tellez, J. L. Casado, F. Dronda, A. Moreno, M. J. Perez-Elias, M. A. Sanfrutos, S. Moreno, C. Quereda, A. Jou, C. Tural, A. Arranz, E. Casas, J. de Miguel, S. Schroeder, J. Sanz, E. Condes, C. Barros, J. Sanz, I. Santos, A. Hernando, V. Rodriguez, R. Rubio, F. Pulido, P. Domingo, J. M. Guardiola, L. Ortiz, E. Ortega, L. : R. Torres, M. Cervero, J. J. Jusdado, M. L. Montes, G. Perez, G. Gaspar, E. Barquilla, B. Mahillo, B. Moyano, M. Cotarelo, E. Aznar, H. Esteban, Effect of accompanying antiretroviral drugs on virological response to pegylated interferon and ribavirin in patients co-infected with HIV and hepatitis C virus, Journal of Antimicrobial Chemotherapy, 2011, 66, 12, 2843

    CrossRef

23. 23
    E. Angeli, A. Mainini, P. Meraviglia, M. Schiavini, E. Ricci, R. Giorgi, G. Gubertini, G. Rizzardini, Eligibility and Feasibility of the Treatment of Chronic Hepatitis C in a Cohort of Italian HIV-Positive Patients at a Single HIV Reference Center, AIDS Patient Care and STDs, 2011, 25, 5, 295

    CrossRef

24. 24
    Vincent Soriano, Eugenia Vispo, Luz Martin-Carbonero, Pablo Barreiro, HCV and HIV Coinfection, Current Hepatitis Reports, 2011, 10, 1, 52

    CrossRef

25. 25
    Barbara H. McGovern, Hepatic Steatosis in HIV/HCV–Coinfected Patients: Time to Reevaluate!, Gastroenterology, 2011, 140, 3, 772

    CrossRef

26. 26
    Massimo Puoti, Roberto Rossotti, Annalisa Garlaschelli, Raffaele Bruno, Hepatocellular carcinoma in HIV hepatitis C virus, Current Opinion in HIV and AIDS, 2011, 6, 6, 534

    CrossRef

27. 27
    L. E. Taylor, M. Holubar, K. Wu, R. J. Bosch, D. L. Wyles, J. A. Davis, K. H. Mayer, K. E. Sherman, K. T. Tashima, Incident Hepatitis C Virus Infection among US HIV-Infected Men Enrolled in Clinical Trials, Clinical Infectious Diseases, 2011, 52, 6, 812

    CrossRef

28. 28
    Deepak Joshi, John O'Grady, Doug Dieterich, Brian Gazzard, Kosh Agarwal, Increasing burden of liver disease in patients with HIV infection, The Lancet, 2011, 377, 9772, 1198

    CrossRef

29. 29
    Marie-Louise C. Vachon, Stephanie H. Factor, Andrea D. Branch, Maria-Isabel Fiel, Maribel Rodriguez-Torres, Norbert Bräu, Richard K. Sterling, Jihad Slim, Andrew H. Talal, Douglas T. Dieterich, Mark S. Sulkowski, Insulin resistance predicts re-treatment failure in an efficacy study of peginterferon-α-2a and ribavirin in HIV/HCV co-infected patients, Journal of Hepatology, 2011, 54, 1, 41

    CrossRef

30. 30
    Susumu Eguchi, Akihiko Soyama, Masaaki Hidaka, Mitsuhisa Takatsuki, Izumi Muraoka, Tetsuo Tomonaga, Takashi Kanematsu, Liver transplantation for patients with human immunodeficiency virus and hepatitis C virus coinfection with special reference to hemophiliac recipients in Japan, Surgery Today, 2011, 41, 10, 1325

    CrossRef

31. 31
    Ulrich Spengler, Management of end-stage liver disease in HIV/hepatitis C virus co-infection, Current Opinion in HIV and AIDS, 2011, 6, 6, 527

    CrossRef

32. 32
    Ashwani K. Singal, Sarat C. Jampana, Bhupinderjit S. Anand, Peginterferon Alfa-2a Is Superior to Peginterferon Alfa-2b in the Treatment of Naïve Patients with Hepatitis C Virus Infection: Meta-Analysis of Randomized Controlled Trials, Digestive Diseases and Sciences, 2011, 56, 8, 2221

    CrossRef

33. 33
    B. L. Pearlman, N. Traub, Sustained Virologic Response to Antiviral Therapy for Chronic Hepatitis C Virus Infection: A Cure and So Much More, Clinical Infectious Diseases, 2011, 52, 7, 889

    CrossRef

34. 34
    Marie-Louise C. Vachon, Douglas T. Dieterich, The HIV/HCV-Coinfected Patient and New Treatment Options, Clinics in Liver Disease, 2011, 15, 3, 585

    CrossRef

35. 35
    B. P. Linas, B. Wang, M. Smurzynski, E. Losina, R. J. Bosch, B. R. Schackman, J. Rong, P. E. Sax, R. P. Walensky, J. Schouten, K. A. Freedberg, The impact of HIV/HCV co-infection on health care utilization and disability: results of the ACTG Longitudinal Linked Randomized Trials (ALLRT) Cohort, Journal of Viral Hepatitis, 2011, 18, 7

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(73K)
    • References
36. You have free access to this content36
    Vincent Mallet, Anaïs Vallet-Pichard, Stanislas Pol, The impact of human immunodeficiency virus on viral hepatitis, Liver International, 2011, 31,

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(226K)
    • References
37. 37
    María López-Diéguez, María L Montes, José F Pascual-Pareja, Carmen Quereda, Miguel A Von Wichmann, Juan Berenguer, Cristina Tural, Asunción Hernando, Juan González-García, Lucia Serrano, José R Arribas, The natural history of liver cirrhosis in HIV–hepatitis C virus-coinfected patients, AIDS, 2011, 25, 7, 899

    CrossRef

38. 38
    Lynn E. Taylor, Sarah E. Bowman, Stacey Chapman, Nickolas Zaller, Michael D. Stein, Patricia A. Cioe, Michaela A. Maynard, Barbara Hedgis McGovern, Treatment for hepatitis C virus genotype 1 infection in HIV-infected individuals on methadone maintenance therapy, Drug and Alcohol Dependence, 2011, 116, 1-3, 233

    CrossRef

39. 39
    L. Martín-Carbonero, P. Tuma, E. Vispo, J. Medrano, P. Labarga, J. González-Lahoz, P. Barreiro, V. Soriano, Treatment of chronic hepatitis C in HIV-infected patients with compensated liver cirrhosis, Journal of Viral Hepatitis, 2011, 18, 8

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(233K)
    • References
40. 40
    Mark G. Swain, Ming–Yang Lai, Mitchell L. Shiffman, W. Graham E. Cooksley, Stefan Zeuzem, Douglas T. Dieterich, Armand Abergel, Mário G. Pessôa, Amy Lin, Andreas Tietz, Edward V. Connell, Moisés Diago, A Sustained Virologic Response Is Durable in Patients With Chronic Hepatitis C Treated With Peginterferon Alfa-2a and Ribavirin, Gastroenterology, 2010, 139, 5, 1593

    CrossRef

41. 41
    Patrice Cacoub, Philippe Halfon, Eric Rosenthal, François Bailly, Firouze Bani Sadr, Yves Benhamou, Stéphane Chevaliez, Jean Michel Pawlotsky, Lionel Piroth, Yazdan Yazdanpanah, Stanislas Pol, Care of hepatitis C virus infection in human immunodeficiency virus-infected patients: Modifications in three consecutive large surveys between 2004 and 2009, Journal of Hepatology, 2010, 53, 2, 230

    CrossRef

42. 42
    J. Macias, J. del Valle, A. Rivero, J. A. Mira, A. Camacho, N. Merchante, I. Perez-Camacho, K. Neukam, A. Rivero-Juarez, R. Mata, J. Torre-Cisneros, J. A. Pineda, Changes in liver stiffness in patients with chronic hepatitis C with and without HIV co-infection treated with pegylated interferon plus ribavirin, Journal of Antimicrobial Chemotherapy, 2010, 65, 10, 2204

    CrossRef

43. 43
    Seyed-Moayed Alavian, Bita Behnava, Seyed Vahid Tabatabaei, Comparative efficacy and overall safety of different doses of consensus interferon for treatment of chronic HCV infection: a systematic review and meta-analysis, European Journal of Clinical Pharmacology, 2010, 66, 11, 1071

    CrossRef

44. 44
    Scott L. Friedman, Evolving challenges in hepatic fibrosis, Nature Reviews Gastroenterology & Hepatology, 2010, 7, 8, 425

    CrossRef

45. 45
    Esperance Schaefer, Raymond T. Chung, HIV and HCV Coinfection: Where Are We in 2010?, Current Hepatitis Reports, 2010, 9, 3, 155

    CrossRef

46. 46
    J. Berenguer, Infección por Virus de Hepatitis C en pacientes coinfectados por el VIH, Revista Clínica Española, 2010, 210, 7, 338

    CrossRef

47. 47
    Pablo Ryan, Salvador Resino, Pilar Miralles, Jaime Cosín, Juan Carlos López, Silvia Moreno, Pilar Catalán, Margarita Ramírez, Isabel Gutiérrez, Juan Berenguer, Insulin Resistance Impairs Response to Interferon Plus Ribavirin in Patients Coinfected With HIV and Hepatitis C Virus, JAIDS Journal of Acquired Immune Deficiency Syndromes, 2010, 55, 2, 176

    CrossRef

48. 48
    Seyed Vahid Tabatabaei, Seyed Moayed Alavian, Maryam Keshvari, Bita Behnava, Seyyed Mohammad Miri, Pegah Karimi Elizee, Farhad Zamani, Sedigheh Amini Kafi-abad, Ahmad Gharehbaghian, Bashir Hajibeigy, Kamran Bagheri Lankarani, Low dose ribavirin for treatment of HCV infected thalassemia major patients: New indications for combination therapy<!– Doctopic: VH –>, Journal of Hepatology, 2010,

    CrossRef

49. 49
    Ira M. Jacobson, Patrice Cacoub, Luigino Dal Maso, Stephen A. Harrison, Zobair M. Younossi, Manifestations of Chronic Hepatitis C Virus Infection Beyond the Liver, Clinical Gastroenterology and Hepatology, 2010, 8, 12, 1017

    CrossRef

50. 50
    Seyed-Moayed Alavian, Seyed Vahid Tabatabaei, Maryam Keshvari, Bita Behnava, Seyyed Mohammad Miri, Pegah Karimi Elizee, Kamran Bagheri Lankarani, Peginterferon α-2a and ribavirin treatment of patients with haemophilia and hepatitis C virus infection: a single-centre study of 367 cases, Liver International, 2010, 30, 8

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(215K)
    • References
51. 51
    Ira M. Jacobson, Gary L. Davis, Hashem El–Serag, Francesco Negro, Christian Trépo, Prevalence and Challenges of Liver Diseases in Patients With Chronic Hepatitis C Virus Infection, Clinical Gastroenterology and Hepatology, 2010, 8, 11, 924

    CrossRef

52. 52
    Ana Moreno, Carmen Quereda, Jesús Fortún, Rafael Bárcena, María J Pérez-Elías, José L Casado, Miguel A Rodríguez-Sagrado, María L Mateos, Carlos Blesa, Santiago Moreno, Safe co-administration of raltegravir, pegylated-interferon and, ribavirin in HIV individuals with hepatitis C virus-related liver damage, AIDS, 2010, 24, 8, 1231

    CrossRef

53. 53
    Xavier Forns, Jordi Bruix, Treating hepatitis C in patients with cirrhosis: The effort is worth it, Journal of Hepatology, 2010, 52, 5, 624

    CrossRef

54. 54
    Frederick L Altice, Adeeba Kamarulzaman, Vincent V Soriano, Mauro Schechter, Gerald H Friedland, Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs, The Lancet, 2010, 376, 9738, 367

    CrossRef

55. 55
    Ramsey Cheung, Ajitha Mannalithara, Gurkirpal Singh, Utilization and Antiviral Therapy in Patients with Chronic Hepatitis C: Analysis of Ambulatory Care Visits in the US, Digestive Diseases and Sciences, 2010, 55, 6, 1744

    CrossRef

56. 56
    Marie-Louise Vachon, Ponni Perumalswami, Douglas T. Dieterich, Hepatobiliary Manifestations of Human Immunodeficiency Virus,

    Direct Link:

    • Summary
    • PDF(1236K)
    • References
57. 57
    Gail V. Matthews, Gregory J. Dore, HIV and Hepatitis C Co-Infection,

    Direct Link:

    • Summary
    • PDF(100K)
    • References